Novo Nordisk (NYSE:NVO) Q3 2025 Conference November 06, 2025 06:40 AM ET Speaker10Welcome to the third quarter, 2025 roadshow for Novo Nordisk. I'm Richard Vosser, European pharma analyst. It's my great pleasure, and that's at JP Morgan, obviously. It's my great pleasure to welcome Karsten, Martin, and Ludwig from the Novo management team to our presentation. There's going to be a short intro, presentation from Karsten and the team, and then we'll go into Q&A. Karsten, over to you. Thanks very much.Speaker4 ...